An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Collegium to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) to participate in investor conferences. Fireside chats at Jefferies 14th Annual Global Healthcare Conference on Nov 14 and Piper Sandler 35th Annual Healthcare Conference on Nov 28. Webcast available on company website.
Positive
None.
Negative
None.
STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
Jefferies 14th Annual Global Healthcare Conference Fireside Chat Date and Time: Tuesday, November 14, 2023, at 9:30 a.m. GMT
Piper Sandler 35th Annual Healthcare Conference Fireside Chat Date and Time: Tuesday, November 28, 2023, at 4:00 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc. Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher James, M.D. Vice President, Investor Relations ir@collegiumpharma.com
What is the latest announcement from Collegium Pharmaceutical, Inc. (Nasdaq: COLL)?
The company will participate in investor conferences and fireside chats at Jefferies 14th Annual Global Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference.
When and where will the fireside chats take place?
The fireside chat at Jefferies conference is on Nov 14 at 9:30 a.m. GMT, and the one at Piper Sandler conference is on Nov 28 at 4:00 p.m. ET.
How can I access the webcast of the fireside chats?
The webcast will be available live on the Investors section of the company's website, with a replay archived for 90 days after the presentation.
collegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the growing problems associated with non-medical use, abuse and misuse of prescription products by leveraging the company’s proprietary deterx® technology platform. deterx technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have a narrow therapeutic index that would benefit from protection against misuse such as breaking, crushing, grinding, or dissolving the product. the deterx technology platform is covered by u.s. and international patents and patent applications. collegium’s lead product candidate, xtampza er™, is an abuse-deterrent, ex
